PanGO Medical Devices Inc.

pangomed.com

PanGO Medical specializes in biomedical research and diagnostics instrumentation, and we have the resources and expertise to provide a range of services --- from niche consultation by our scientists on medical technologies such as optics, electrochemistry, spectrometry, and fluidics, to full turn-key solutions for design, development, and manufacturing.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

RANOK THERAPEUTICS ANNOUNCES AGREEMENT WITH PFIZER ON TARGETED PROTEIN DEGRADATION

Ranok Therapeutics | November 30, 2021

news image

Ranok Therapeutics Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, announced an agreement with Pfizer Inc. to apply and evaluate Ranok’s CHAMP™ platform technology on an undisclosed cancer target. Terms of the agreement were not disclosed. Ranok has developed a proprietary and innovative targeted protein degradation (TPD) platform technology, CHAMP™ (Chaperone-mediated Protein Deg...

Read More

Business Insights

SIO2 MATERIALS SCIENCE AND DOOSAN CORPORATION ENTER INTO STRATEGIC PARTNERSHIP TO ACCELERATE MARKET DEVELOPMENT IN ASIA

SiO2 Materials Science | December 27, 2021

news image

Doosan Corporation, founded in 1896, one of South Korea's largest diversified conglomerates, and SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, announced an exclusive partnership to sell, market, and distribute SIO2's vial, syringes and blood collection tubes in Asia/Oceania. The partnership will focus initially on the pharmaceutical and diagnostics...

Read More

BIG PHARMA GROUNDS EMPLOYEES: GSK, BRISTOL, ROCHE, SANOFI AND MORE LIMIT TRAVEL DUE TO CORONAVIRUS

FiercePharma | March 06, 2020

news image

Biopharma companies are hunkering down as the COVID-19 epidemic breaks out worldwide. In a FiercePharma survey of biopharma companies late last month, most drugmakers said they were simply limiting travel to hard-hit countries such as China, South Korea and Italy. Now, as more cases pop up across the U.S., Europe and Asia, their tone has shifted. GlaxoSmithKline has “instructed all employees to postpone non-critical international business travel until further notice,” a spokesman sai...

Read More

Pharma Tech

N-LOREM FOUNDATION PARTNERS WITH ALNYLAM TO EXPAND TECHNOLOGY ACCESS TO RNAI THERAPEUTICS FOR PATIENTS WITH NANO-RARE DISEASES

n-Lorem a nonprofit Foundation | January 20, 2022

news image

n-Lorem, a nonprofit Foundation, discovering and providing experimental antisense oligonucleotide medicines to nano-rare disease patients for free, for life, today announced a new partnership with Alnylam Pharmaceuticals Inc. “Discovering, developing and providing individualized medicines for nano-rare patients is a monumental task. At n-Lorem, using ASO technology, we take advantage of three decades of experience, unparalleled quality control and integrated safety databases...

Read More
news image

Pharma Tech

RANOK THERAPEUTICS ANNOUNCES AGREEMENT WITH PFIZER ON TARGETED PROTEIN DEGRADATION

Ranok Therapeutics | November 30, 2021

Ranok Therapeutics Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, announced an agreement with Pfizer Inc. to apply and evaluate Ranok’s CHAMP™ platform technology on an undisclosed cancer target. Terms of the agreement were not disclosed. Ranok has developed a proprietary and innovative targeted protein degradation (TPD) platform technology, CHAMP™ (Chaperone-mediated Protein Deg...

Read More
news image

Business Insights

SIO2 MATERIALS SCIENCE AND DOOSAN CORPORATION ENTER INTO STRATEGIC PARTNERSHIP TO ACCELERATE MARKET DEVELOPMENT IN ASIA

SiO2 Materials Science | December 27, 2021

Doosan Corporation, founded in 1896, one of South Korea's largest diversified conglomerates, and SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, announced an exclusive partnership to sell, market, and distribute SIO2's vial, syringes and blood collection tubes in Asia/Oceania. The partnership will focus initially on the pharmaceutical and diagnostics...

Read More
news image

BIG PHARMA GROUNDS EMPLOYEES: GSK, BRISTOL, ROCHE, SANOFI AND MORE LIMIT TRAVEL DUE TO CORONAVIRUS

FiercePharma | March 06, 2020

Biopharma companies are hunkering down as the COVID-19 epidemic breaks out worldwide. In a FiercePharma survey of biopharma companies late last month, most drugmakers said they were simply limiting travel to hard-hit countries such as China, South Korea and Italy. Now, as more cases pop up across the U.S., Europe and Asia, their tone has shifted. GlaxoSmithKline has “instructed all employees to postpone non-critical international business travel until further notice,” a spokesman sai...

Read More
news image

Pharma Tech

N-LOREM FOUNDATION PARTNERS WITH ALNYLAM TO EXPAND TECHNOLOGY ACCESS TO RNAI THERAPEUTICS FOR PATIENTS WITH NANO-RARE DISEASES

n-Lorem a nonprofit Foundation | January 20, 2022

n-Lorem, a nonprofit Foundation, discovering and providing experimental antisense oligonucleotide medicines to nano-rare disease patients for free, for life, today announced a new partnership with Alnylam Pharmaceuticals Inc. “Discovering, developing and providing individualized medicines for nano-rare patients is a monumental task. At n-Lorem, using ASO technology, we take advantage of three decades of experience, unparalleled quality control and integrated safety databases...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us